STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] TerrAscend Corp. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

TerrAscend ownership update: Multiple reporting persons affiliated with JW Asset Management reported changes to their holdings in TerrAscend Corp. following distributions on August 27, 2025 that reduced fund-level positions. The filing shows specific beneficial ownership counts: JW Asset Management reports 82,814,306 shares (26.19%), JW GP reports 82,654,322 shares (26.14%), JW Partners reports 57,621,892 shares (18.40%), JW Opportunities Fund reports 22,532,576 shares (7.29%) and Jason G. Wild reports 93,775,822 shares (29.54%).

The distributions arose from liquidations and a share-class closure; as part of the distributions Jason Wild received and continues to hold 6,300,567 shares. The filing also discloses a June 24, 2025 grant of 1,364,423 restricted stock units to Jason Wild and the expiration on June 23, 2025 of warrants to purchase 400,001 shares with strike prices above market.

Positive
  • Detailed disclosure of beneficial ownership with exact share counts and percentages for each reporting person
  • RSU grant disclosed (1,364,423 restricted stock units to Jason Wild) providing clarity on insider compensation and alignment
  • Out-of-the-money warrants expired (400,001 warrants), removing potential near-term dilution from those instruments
Negative
  • High ownership concentration: Jason G. Wild beneficially owns 93,775,822 shares (29.54%), and related entities collectively hold >26% in some cases
  • Reductions due to fund liquidations/distributions (August 27, 2025) decreased institutional holdings, which may affect block liquidity and shareholder composition

Insights

TL;DR: Concentrated ownership near 30% by an insider-affiliated group is material and may affect control and liquidity.

The aggregated positions disclosed are large: Jason Wild is reported as beneficially owning 93,775,822 shares (29.54%) and the Advisor entities hold between ~7.3% and ~26.2% individually. These percentages are calculated using 306,233,661 outstanding shares per the issuer's August 7, 2025 filing. The August 27, 2025 distributions reduced fund holdings due to liquidations and a share-class closure, and Jason Wild received 6,300,567 distributed shares which he continues to hold. The RSU grant of 1,364,423 units increases potential insider-aligned economic exposure while warrants for 400,001 shares expired out-of-the-money, removing potential future dilution from those instruments.

TL;DR: Transparent Schedule 13D/A disclosure clarifies group relationships and voting/dispositive powers; material for governance assessments.

The filing clearly itemizes shared and sole voting and dispositive powers across reporting persons, showing mostly shared control (no sole voting power for entities, except Wild's sole voting/dispositive power on 10,961,516 shares). It documents the group status under Section 13(d)(3) and disclaims ownership beyond pecuniary interest. The changes stem from fund liquidations and share-class closures rather than open-market trades, which is important context for board and investor governance review.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


JW PARTNERS, LP
Signature:/s/ Jason Klarreich
Name/Title:Jason Klarreich, Attorney-In-Fact
Date:08/27/2025
JW OPPORTUNITIES FUND, LLC
Signature:/s/ Jason Klarreich
Name/Title:Jason Klarreich, Attorney-In-Fact
Date:08/27/2025
JW ASSET MANAGEMENT, LLC
Signature:/s/ Jason G. Wild
Name/Title:Jason G. Wild, Managing Member
Date:08/27/2025
Signature:/s/ Jason Klarreich
Name/Title:Jason Klarreich, Attorney-In-Fact
Date:08/27/2025
JW GP, LLC
Signature:/s/ Jason Klarreich
Name/Title:Jason Klarreich, Attorney-In-Fact
Date:08/27/2025
JASON G. WILD
Signature:/s/ Jason Klarreich
Name/Title:Jason Klarreich, Attorney-In-Fact
Date:08/27/2025
Comments accompanying signature:
Pursuant to that certain Power of Attorney dated February 14, 2022 with respect to securities of TerrAscend Corp., the original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See SS240.13d-7 for other parties for whom copies are to be sent.

FAQ

How many TerrAscend (TSNDF) shares does Jason G. Wild beneficially own after this filing?

The filing reports Jason G. Wild as beneficially owning 93,775,822 shares (29.54%) of TerrAscend common shares as of August 27, 2025.

What caused the change in JW-affiliated holdings disclosed on August 27, 2025?

The filing states distributions of 14,715,981 shares to investors in connection with the full liquidation of JW Select Investments, LP and the closure of a share class within JW Opportunities Fund, LLC, which reduced fund-level holdings.

Were there any insider awards or expirations disclosed in the Schedule 13D/A?

Yes. The filing discloses a grant of 1,364,423 restricted stock units to Jason Wild on June 24, 2025, and the expiration on June 23, 2025 of warrants to purchase 400,001 shares with strike prices above market.

What percent of TerrAscend is owned by JW Asset Management according to this filing?

JW Asset Management reported beneficial ownership of 82,814,306 shares, representing 26.19% of the outstanding common shares per the filing.

Do the reporting persons claim a group relationship in this filing?

Yes. The filing indicates each Reporting Person may be deemed part of a group with the others under Section 13(d)(3), and each disclaims beneficial ownership beyond pecuniary interest where applicable.
Terrascent

OTC:TSNDF

TSNDF Rankings

TSNDF Latest News

TSNDF Latest SEC Filings

TSNDF Stock Data

298.73M
219.57M
6.31%
2.36%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
King of Prussia